Dopamine and Cognition
Bromocriptine, a dopamine agonist, has potential implications for enhancing working memory and cognitive function, yet pharmaceutical companies have largely overlooked this avenue despite existing data. The tight link between dopamine depletion and impaired cognitive processes raises questions about the industry's reluctance to develop cognitive-enhancing drugs. Insights reveal a missed opportunity for significant therapeutic advancements in executive function.In this clip
From this podcast
Huberman Lab
Dr. Mark D'Esposito: How to Optimize Cognitive Function & Brain Health
Related Questions
Which drug does Mark D'Esposito favor for improving working memory in his studies, guanfacine or bromocriptine, as discussed in the episode Tools to Enhance Working Memory & Attention and the clip Dopamine and Memory?
Which drug does Mark D'Esposito favor for improving working memory in his studies, guanfacine or bromocriptine?
What does Andrew Huberman have to say about dopamine synthesis, pharmacological tools, and behavioral optimization for supporting the process?